|
Volumn 28, Issue 4 SUPPL. 14, 2001, Pages 1-2
|
Current perspectives in the treatment of non-small cell lung cancer: Introduction
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
CARBOPLATIN;
CISPLATIN;
GEMCITABINE;
PACLITAXEL;
BONE MARROW SUPPRESSION;
CANCER COMBINATION CHEMOTHERAPY;
CANCER INHIBITION;
CANCER MORTALITY;
CANCER RADIOTHERAPY;
CANCER STAGING;
CANCER SURVIVAL;
CAUSE OF DEATH;
CLINICAL TRIAL;
DNA DETERMINATION;
DRUG EFFICACY;
DRUG SAFETY;
EDITORIAL;
GENE THERAPY;
HUMAN;
LUNG CANCER;
LUNG NON SMALL CELL CANCER;
MULTIMODALITY CANCER THERAPY;
PERIPHERAL NEUROPATHY;
PRIORITY JOURNAL;
RADIOSENSITIVITY;
TOXICITY;
TREATMENT OUTCOME;
|
EID: 0034792287
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: 10.1053/sonc.2001.27604 Document Type: Editorial |
Times cited : (5)
|
References (0)
|